Marker for diagnosing liver cancer containing anti-ATIC autoantibody, and composition for diagnosing liver cancer containing antigen thereof

An autoimmune antibody and composition technology, applied in the field of cleotide formyltransfera, can solve the problems of limited implementation, low practicability, and little diagnostic effect, and achieve effective development results

Active Publication Date: 2014-04-16
KOREA RES INST OF BIOSCI & BIOTECH
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, there is a problem that it can be detected when the antigenic determinant is an ordinal epitope depending on the protein sequence, but cannot be detected when it is a hypothetical epitope depending on the protein structure
[0010] As mentioned above, studies on autoimmune antibodies that can be used as existing markers related to cancer occurrence are not very practical and have little diagnosti

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Marker for diagnosing liver cancer containing anti-ATIC autoantibody, and composition for diagnosing liver cancer containing antigen thereof
  • Marker for diagnosing liver cancer containing anti-ATIC autoantibody, and composition for diagnosing liver cancer containing antigen thereof
  • Marker for diagnosing liver cancer containing anti-ATIC autoantibody, and composition for diagnosing liver cancer containing antigen thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0082] Example 1: Obtain XC154 autoimmune antibodies derived from HBx mice

[0083] In order to obtain the autoimmune antibodies that are produced when cancer occurs, HBx transformed mice are used. It is known that the liver cancer that occurs is similar to human liver cancer. From HBx-transformed mice in rearing, spleen cells of individuals confirmed to have liver cancer were taken and used as B cells, and cell fusion with mouse myeloma cells Sp2 / 0 was carried out to prepare B cell hybridomas cell. The cell fusion is based on the general preparation method of B-cell hybridoma cells. The fused cells were screened once using hypoxanthine-aminopt erin-thymidine medium (HAT medium), and only the cells that formed clones were cultured. Re-select cells that can detect cancer cell-reactive antibodies in the cell culture medium and continue to culture.

[0084] The reactivity of autoimmune antibodies to cancer cells is confirmed by intracellular staining of fixed and permeabilized canc...

Example Embodiment

[0086] Example 2: Analysis of Complementary Determining Region (CDR) of XC154 antibody and purification of antibody

[0087] After confirming that the XC154 antibody can specifically recognize the antigen expressed in cancer cells, in order to obtain information about the antigen recognition specificity of the XC154 antibody, the complementarity determining region sequence of the antibody was analyzed. The detailed method is as follows:

[0088] Collect 10 6 About two XC154 antibody producing cells, use RNA extraction kit (Q iagen) to extract total RNA. CDNA was synthesized from 5μg of total RNA using the complementary DNA (cDNA synthesis) kit (Invitrogen), and the synthesized 1μg cDNA and mouse heavy chain constant region primers (Mou se Heavy chain constant region primer) F5'-CTT CCG GAA TTC S AR GTN MAG CTG SAG SAG TCW GG-3' (SEQ NO.21), R5'-GGA AGA TCT GAC ATT TGG GAA GGA CTG ACT CTC-3' (S EQ NO .22) and Mouse light chain constant reg ion primer F5'-GGG AGC TCG AYAT TGT GMT S...

Example Embodiment

[0090] Example 3: Confirmation of the expression of XC154 antibody specific reactive antigen in various cancer cells

[0091] In order to confirm the reactivity of the XC154 antibody to a variety of cancer cell lines, various cancer cells were stained intracellularly using the method of Example 1 above, and then analyzed by flow cytometry ( image 3 ). From the results, it was confirmed that the XC154 antibody-reactive protein was overexpressed in liver cancer cell lines such as HepG2, SK-Hep-1, and various types of cancer cell lines such as HeLa, LNcap-LN3, and A549.

[0092] In addition, in order to confirm the expression position in the cell, intracellular staining is performed and then observed with a confocal fluorescence microscope. A relatively strong staining can be confirmed at the position of the cytoplasm or the position of the cell membrane ( image 3 ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a fragment comprising an autoantibody which specifically binds to ATIC or an antigen-binding site (i.e. paratope) of the autoantibody, a composition for diagnosing liver cancer containing an agent which measures the expression level of the fragment, a hybridoma cell line producing the autoantibody, a diagnostic kit for liver cancer containing the composition, a method for diagnosing liver using the composition, and a method for screening a liver cancer therapeutic agent using the autoantibody. Using the anti-ATIC specific autoantibody of the present invention as a marker for diagnosing liver cancer, the occurrence of liver cancer can be diagnosed using a non-invasive biological sample such as blood, plasma, serum, lymph tissue, and the like, with a sensitivity of about 87% and a specificity of about 88%, and as liver cancer can be easily diagnosed using an amino acid sequence identified in the present invention, the autoantibody is effective for developing a diagnostic kit for liver cancer.

Description

technical field [0001] The present invention relates to a self-specific combination with ATIC (5-aminoimidazole-4-carboxamide ribon ucleotide formyltransferase / IMP cyclohydrolase, 5-aminoimidazole-4-carboxamide nucleotide formyltransferase / IMP cyclohydrolase) Immune antibody (auto antibody) or a fragment containing its antigen-binding site (antigen-binding site, Paratope); an antigen fragment that specifically binds to the autoimmune antibody; A composition for diagnosis of liver cancer according to the expression level of fragments of the antigen-combining site; a hybridoma cell line producing the autoimmune antibody and a kit for diagnosis of liver cancer comprising the composition of the present invention. Furthermore, the present invention relates to a method for diagnosing liver cancer using the composition of the present invention and a method for screening a therapeutic agent for liver cancer using the autoimmune antibody. Background technique [0002] In South Korea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/30G01N33/53G01N33/574C12N5/16
CPCC07K16/40G01N33/564G01N33/57438C07K16/30C12N5/16G01N33/53G01N33/574
Inventor 赵恩伟许昌圭高正宪禹美京兪香淑黃海民
Owner KOREA RES INST OF BIOSCI & BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products